Thursday, May 24, 2012
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?26 May 2011
White Papers
Focus Area: Drug Discovery
High Standards
Standardization across the whole spectrum of clinical trials is vitally important. NGP talks to CDISC’s Dave Iberson-Hurst and Tim Jaeger about the challenges of achieving this goal.
No Comments
It’s All in the Genes
An update on the latest research into using siRNA to target tumors. By Yu Shen, Abbott Laboratories
No Comments
Making the Leap
Brian Kotzin, Vice President of Medical Sciences at Amgen tells NGP how biomarkers help translate basic science into medicine.
No Comments
Going Digital
Shealynn Harris tells NGP about the benefits of using digital pathology in international clinical trials.
No Comments
Challenges in Discovery Informatics and the Cost of Research Productivity
Accessing, analyzing, and sharing molecular discovery research data is an expensive and time consuming process at many pharmaceutical organizations. By Tripos
No Comments
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.